Medicare Program; Implementation of Prior Authorization Process for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Items and Publication of the Initial Required Prior Authorization List of DMEPOS Items That Require Prior Authorization as a Condition of Payment, 93636-93637 [2016-30273]
Download as PDF
93636
Federal Register / Vol. 81, No. 245 / Wednesday, December 21, 2016 / Rules and Regulations
EPA proposes to take on the exemption
petitions.
apply the two standards enunciated in
TSCA section 6(e)(3)(B).
§§ 750.14 and 750.15
J. Executive Order 12898: Federal
Actions To Address Environmental
Justice in Minority Populations and
Low-Income Populations
[FR Doc. 2016–30055 Filed 12–20–16; 8:45 am]
[Removed]
5. Remove §§ 750.14 and 750.15.
This action does not establish an
environmental health or safety standard,
and is therefore not is not subject to
environmental justice considerations
under Executive Order 12898 (59 FR
7629, February 16, 1994), because it
does not establish an environmental
health or safety standard. This
regulatory action is a procedural change
and does not have any impact on human
health or the environment.
■
K. Congressional Review Act (CRA)
§ 750.15
This rule is exempt from the CRA (5
U.S.C. 801 et seq.) because it is a rule
of agency organization, procedure or
practice that does not substantially
affect the rights or obligations of nonagency parties.
(a) [Reserved]
(b) EPA will grant or deny petitions
under TSCA section 6(e)(3)(B)
submitted pursuant to § 750.11.
(c) In determining whether to grant an
exemption to the PCB ban, the Agency
shall apply the two standards
enunciated in TSCA section 6(e)(3)(B).
■ 9. Revise § 750.30 to read as follows:
List of Subjects in 40 CFR Part 750
Administrative practice and
procedure, Chemicals, Environmental
protection, Hazardous substances.
§ 750.16
■
6. Redesignate § 750.16 as § 750.14.
§§ 750.17 through 750.20
■
Therefore, 40 CFR chapter I is
amended as follows:
PART 750—PROCEDURES FOR
RULEMAKING UNDER SECTION 6 OF
THE TOXIC SUBSTANCES CONTROL
ACT [AMENDED]
§§ 750.21
Authority: 15 U.S.C. 2605.
Subpart A—[Removed and Reserved]
2. Subpart A, consisting of §§ 750.1
through 750.9 and an appendix, is
removed and reserved.
■ 3. Revise § 750.10 to read as follows:
■
§ 750.10
8. Redesignate § 750.21 as § 750.15,
and revise it to read as follows:
asabaliauskas on DSK3SPTVN1PROD with RULES
Notice of proposed rulemaking.
Rulemaking for PCB exemptions filed
pursuant to § 750.11(a) shall begin with
the publication of a notice of proposed
rulemaking in the Federal Register. The
notice shall state in summary form the
required information described in
§ 750.11(c). Due to time constraints, the
notice need not indicate what action
17:05 Dec 20, 2016
Jkt 241001
Applicability
Sections 750.30 through 750.35 apply
to all rulemakings under authority of
section 6(e)(3)(B) of the Toxic
Substances Control Act (TSCA), 15
U.S.C. 2605(e)(3)(B) with respect to
petitions for PCB processing and
distribution in commerce exemptions
filed pursuant to § 750.31(a).
■ 10. Revise § 750.33 to read as follows:
Notice of proposed rulemaking.
Rulemaking for PCB exemptions filed
pursuant to § 750.31(a) shall begin with
the publication of a notice of proposed
rulemaking in the Federal Register. The
notice shall state in summary form the
required information described in
§ 750.31(c).
■
Applicability
VerDate Sep<11>2014
Final rule.
§§ 750.34 and 750.35
Sections 750.10–750.15 apply to all
rulemakings under authority of section
6(e)(3)(B) of the Toxic Substances
Control Act (TSCA), 15 U.S.C.
2605(e)(3)(B) with respect to petitions
filed pursuant to § 750.11(a).
■ 4. Revise § 750.13 to read as follows:
§ 750.13
[Redesignated as § 750.15]
■
§ 750.33
1. The authority citation for part 750
continues to read as follows:
■
[Removed]
7. Remove §§ 750.17 through 750.20.
§ 750.30
Dated: December 8, 2016.
Gina McCarthy,
Administrator.
[Redesignated as § 750.14]
§ 750.36
■
[Removed]
11. Remove §§ 750.34 and 750.35.
[Redesignated as § 750.34]
12. Redesignate § 750.36 as § 750.34.
§§ 750.37 through 750.40
■
[Removed]
13. Remove §§ 750.37 through 750.40.
§ 750.41
[Redesignated as § 750.35]
14. Redesignate § 750.41 as § 750.35,
and revise it to read as follows:
■
§ 750.35
Final rule.
(a) [Reserved]
(b) EPA will grant or deny petitions
under TSCA section 6(e)(3)(B)
submitted pursuant to § 750.31.
(c) In determining whether to grant an
exemption to the PCB ban, EPA will
PO 00000
Frm 00066
Fmt 4700
Sfmt 4700
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
42 CFR Part 414
[CMS–6072–N]
Medicare Program; Implementation of
Prior Authorization Process for Certain
Durable Medical Equipment,
Prosthetics, Orthotics, and Supplies
(DMEPOS) Items and Publication of the
Initial Required Prior Authorization List
of DMEPOS Items That Require Prior
Authorization as a Condition of
Payment
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Implementation of list and
phases.
AGENCY:
This document announces the
implementation of the prior
authorization program for certain
durable medical equipment, prosthetics,
orthotics, and supplies (DMEPOS) items
in two phases and the issuance of the
initial Required Prior Authorization List
of DMEPOS items that require prior
authorization as a condition of payment.
DATES: Phase one of implementation is
effective on March 20, 2017. Phase two
of implementation is effective on July
17, 2017.
FOR FURTHER INFORMATION CONTACT:
Jennifer Phillips, (410) 786–1023.
Linda O’Hara (410) 786–8347.
Scott Lawrence (410) 786–4313.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
Sections 1832, 1834, and 1861 of the
Social Security Act (the Act) establish
that the provision of durable medical
equipment, prosthetic, orthotics, and
supplies (DMEPOS) is a covered benefit
under Part B of the Medicare program.
Section 1834(a)(15) of the Act
authorizes the Secretary to develop and
periodically update a list of DMEPOS
items that the Secretary determines, on
the basis of prior payment experience,
are frequently subject to unnecessary
utilization and to develop a prior
authorization process for these items.
In the December 30, 2015 final rule
(80 FR 81674), titled ‘‘Medicare
Program; Prior Authorization Process for
Certain Durable Medical Equipment,
E:\FR\FM\21DER1.SGM
21DER1
Federal Register / Vol. 81, No. 245 / Wednesday, December 21, 2016 / Rules and Regulations
asabaliauskas on DSK3SPTVN1PROD with RULES
Prosthetics, Orthotics, and Supplies’’,
we implemented section 1834(a)(15) of
the Act by establishing an initial Master
List (called the Master List of Items
Frequently Subject to Unnecessary
Utilization) of certain DMEPOS that the
Secretary determined, on the basis of
prior payment experience, are
frequently subject to unnecessary
utilization and by establishing a prior
authorization process for these items.
The Master List is self-updating
annually, and items remain on the
Master List for 10 years from the date
the item was added to the Master List.
Items are removed from the list sooner
than 10 years if the purchase amount
drops below the payment threshold
described later in this section. We will
notify the public annually of any
additions and deletions from the Master
List by posting the notification in the
Federal Register and on the CMS Prior
Authorization Web site. The Master List
includes items that meet the following
criteria:
++ Appear on the DMEPOS Fee
Schedule list.
++ Have an average purchase fee of
$1,000 or greater (adjusted annually for
inflation) or an average monthly rental
fee schedule of $100 or greater (adjusted
annually for inflation). (These dollar
amounts are referred to as the payment
threshold).
++ Meet either of the following
criteria:
—Identified in a Government
Accountability Office (GAO) or
Department of Health and Human
Services Office of Inspector General
(OIG) report that is national in scope
and published in 2007 or later as having
a high rate of fraud or unnecessary
utilization.
—Listed in the 2011 or later
Comprehensive Error Rate Testing
(CERT) program’s Annual Medicare FeeFor-Service (FFS) Improper Payment
Rate Report and/or the Supplementary
Appendices for the Medicare Fee-forService Improper Payments Report.
II. Provisions of the Document
In the December 30, 2015 final rule
(80 FR 81689), we stated that we would
inform the public of those DMEPOS
items on the Required Prior
Authorization List in the Federal
Register with 60-day notice before
implementation. The Required Prior
Authorization List specified in
§ 414.234(c)(1) is selected from the
Master List of Items Frequently Subject
to Unnecessary Utilization (as described
in § 414.234(b)(1)), and items on the
Required Prior Authorization List
require prior authorization as a
condition of payment. Additionally, we
VerDate Sep<11>2014
17:05 Dec 20, 2016
Jkt 241001
stated that CMS may elect to limit the
prior authorization requirement to a
particular region of the country if claims
data analysis shows that unnecessary
utilization of the selected item(s) is
concentrated in a particular region. The
purpose of this document is to inform
the public that we are implementing the
prior authorization program for certain
DMEPOS items and to provide the
initial Required Prior Authorization List
of DMEPOS items that require prior
authorization as a condition of payment.
To assist stakeholders in preparing for
implementation of the prior
authorization program, CMS is
providing 90 days’ notice.
The following two DMEPOS items,
represented by HCPCS (Healthcare
Common Procedure Coding System)
codes K0856 and K0861 are added to
the Required Prior Authorization List:
• K0856 HCPCS: Power wheelchair,
group 3 standard, single power option,
sling/solid seat/back, patient weight
capacity up to and including 300
pounds.
• K0861 HCPCS: Power wheelchair,
group 3 standard, multiple power
option, sling/solid seat/back, patient
weight capacity up to and including 300
pounds.
Power wheelchairs, represented by
HCPCS codes K0856 and K0861, will be
subject to the requirements of the prior
authorization program for certain
DMEPOS items as outlined in § 414.234.
(We note that these Group 3 power
wheelchairs are not part of the separate
Prior Authorization of Power Mobility
Devices (PMDs) Demonstration.)
We will implement a national prior
authorization program for K0856 and
K0861 in two phases, as specified in the
DATES section of this document. We are
implementing the program in this
manner to test the new prior
authorization program because new
complex claims processing systems
changes are required for
implementation. This phased-in
approach will allow us to identify and
resolve any unforeseen issues by using
a smaller claim volume in phase one
before national implementation occurs
in phase two.
In phase one of implementation,
which begins as specified in the DATES
section of this document, we will limit
the prior authorization requirement to
one state in each of the four DME
Medicare Administrative Contractors
(MAC) geographic jurisdictions, as
follows: Illinois, Missouri, New York,
and West Virginia. Initially limiting the
program to one state in each of the DME
MAC geographic jurisdictions allows us
to test the national claims processing
system and the local DME MAC
PO 00000
Frm 00067
Fmt 4700
Sfmt 9990
93637
processes. In phase two, which begins
as specified in the DATES section of this
document, we will expand the program
to the remaining states.
Prior to furnishing the item to the
beneficiary and prior to submitting the
claim for processing, a requester must
submit a prior authorization request that
includes evidence that the item
complies with all applicable Medicare
coverage, coding, and payment rules.
Consistent with § 414.234(d), such
evidence must include the order,
relevant information from the
beneficiary’s medical record, and
relevant supplier-produced
documentation. After receipt of all
applicable required Medicare
documentation, CMS or one of its
review contractors will conduct a
medical review and communicate a
decision that provisionally affirms or
non-affirms the request.
We will issue specific prior
authorization guidance in subregulatory
communications, including final
timelines, which are customized for the
DMEPOS item subject to prior
authorization, for communicating a
provisionally affirmed or non-affirmed
decision to the requester. In the
December 30, 2015 final rule, we stated
that this approach to final timelines
provides flexibility to develop a process
that involves fewer days, as may be
appropriate, and allows us to safeguard
beneficiary access to care. If at any time
we become aware that the prior
authorization process is creating barriers
to care, we can suspend the program.
III. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
Dated: December 1, 2016.
Andrew M. Slavitt,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2016–30273 Filed 12–19–16; 4:15 pm]
BILLING CODE 4120–01–P
E:\FR\FM\21DER1.SGM
21DER1
Agencies
[Federal Register Volume 81, Number 245 (Wednesday, December 21, 2016)]
[Rules and Regulations]
[Pages 93636-93637]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30273]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Part 414
[CMS-6072-N]
Medicare Program; Implementation of Prior Authorization Process
for Certain Durable Medical Equipment, Prosthetics, Orthotics, and
Supplies (DMEPOS) Items and Publication of the Initial Required Prior
Authorization List of DMEPOS Items That Require Prior Authorization as
a Condition of Payment
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Implementation of list and phases.
-----------------------------------------------------------------------
SUMMARY: This document announces the implementation of the prior
authorization program for certain durable medical equipment,
prosthetics, orthotics, and supplies (DMEPOS) items in two phases and
the issuance of the initial Required Prior Authorization List of DMEPOS
items that require prior authorization as a condition of payment.
DATES: Phase one of implementation is effective on March 20, 2017.
Phase two of implementation is effective on July 17, 2017.
FOR FURTHER INFORMATION CONTACT:
Jennifer Phillips, (410) 786-1023.
Linda O'Hara (410) 786-8347.
Scott Lawrence (410) 786-4313.
SUPPLEMENTARY INFORMATION:
I. Background
Sections 1832, 1834, and 1861 of the Social Security Act (the Act)
establish that the provision of durable medical equipment, prosthetic,
orthotics, and supplies (DMEPOS) is a covered benefit under Part B of
the Medicare program.
Section 1834(a)(15) of the Act authorizes the Secretary to develop
and periodically update a list of DMEPOS items that the Secretary
determines, on the basis of prior payment experience, are frequently
subject to unnecessary utilization and to develop a prior authorization
process for these items.
In the December 30, 2015 final rule (80 FR 81674), titled
``Medicare Program; Prior Authorization Process for Certain Durable
Medical Equipment,
[[Page 93637]]
Prosthetics, Orthotics, and Supplies'', we implemented section
1834(a)(15) of the Act by establishing an initial Master List (called
the Master List of Items Frequently Subject to Unnecessary Utilization)
of certain DMEPOS that the Secretary determined, on the basis of prior
payment experience, are frequently subject to unnecessary utilization
and by establishing a prior authorization process for these items. The
Master List is self-updating annually, and items remain on the Master
List for 10 years from the date the item was added to the Master List.
Items are removed from the list sooner than 10 years if the purchase
amount drops below the payment threshold described later in this
section. We will notify the public annually of any additions and
deletions from the Master List by posting the notification in the
Federal Register and on the CMS Prior Authorization Web site. The
Master List includes items that meet the following criteria:
++ Appear on the DMEPOS Fee Schedule list.
++ Have an average purchase fee of $1,000 or greater (adjusted
annually for inflation) or an average monthly rental fee schedule of
$100 or greater (adjusted annually for inflation). (These dollar
amounts are referred to as the payment threshold).
++ Meet either of the following criteria:
--Identified in a Government Accountability Office (GAO) or
Department of Health and Human Services Office of Inspector General
(OIG) report that is national in scope and published in 2007 or later
as having a high rate of fraud or unnecessary utilization.
--Listed in the 2011 or later Comprehensive Error Rate Testing
(CERT) program's Annual Medicare Fee-For-Service (FFS) Improper Payment
Rate Report and/or the Supplementary Appendices for the Medicare Fee-
for-Service Improper Payments Report.
II. Provisions of the Document
In the December 30, 2015 final rule (80 FR 81689), we stated that
we would inform the public of those DMEPOS items on the Required Prior
Authorization List in the Federal Register with 60-day notice before
implementation. The Required Prior Authorization List specified in
Sec. 414.234(c)(1) is selected from the Master List of Items
Frequently Subject to Unnecessary Utilization (as described in Sec.
414.234(b)(1)), and items on the Required Prior Authorization List
require prior authorization as a condition of payment. Additionally, we
stated that CMS may elect to limit the prior authorization requirement
to a particular region of the country if claims data analysis shows
that unnecessary utilization of the selected item(s) is concentrated in
a particular region. The purpose of this document is to inform the
public that we are implementing the prior authorization program for
certain DMEPOS items and to provide the initial Required Prior
Authorization List of DMEPOS items that require prior authorization as
a condition of payment. To assist stakeholders in preparing for
implementation of the prior authorization program, CMS is providing 90
days' notice.
The following two DMEPOS items, represented by HCPCS (Healthcare
Common Procedure Coding System) codes K0856 and K0861 are added to the
Required Prior Authorization List:
K0856 HCPCS: Power wheelchair, group 3 standard, single
power option, sling/solid seat/back, patient weight capacity up to and
including 300 pounds.
K0861 HCPCS: Power wheelchair, group 3 standard, multiple
power option, sling/solid seat/back, patient weight capacity up to and
including 300 pounds.
Power wheelchairs, represented by HCPCS codes K0856 and K0861, will
be subject to the requirements of the prior authorization program for
certain DMEPOS items as outlined in Sec. 414.234. (We note that these
Group 3 power wheelchairs are not part of the separate Prior
Authorization of Power Mobility Devices (PMDs) Demonstration.)
We will implement a national prior authorization program for K0856
and K0861 in two phases, as specified in the DATES section of this
document. We are implementing the program in this manner to test the
new prior authorization program because new complex claims processing
systems changes are required for implementation. This phased-in
approach will allow us to identify and resolve any unforeseen issues by
using a smaller claim volume in phase one before national
implementation occurs in phase two.
In phase one of implementation, which begins as specified in the
DATES section of this document, we will limit the prior authorization
requirement to one state in each of the four DME Medicare
Administrative Contractors (MAC) geographic jurisdictions, as follows:
Illinois, Missouri, New York, and West Virginia. Initially limiting the
program to one state in each of the DME MAC geographic jurisdictions
allows us to test the national claims processing system and the local
DME MAC processes. In phase two, which begins as specified in the DATES
section of this document, we will expand the program to the remaining
states.
Prior to furnishing the item to the beneficiary and prior to
submitting the claim for processing, a requester must submit a prior
authorization request that includes evidence that the item complies
with all applicable Medicare coverage, coding, and payment rules.
Consistent with Sec. 414.234(d), such evidence must include the order,
relevant information from the beneficiary's medical record, and
relevant supplier-produced documentation. After receipt of all
applicable required Medicare documentation, CMS or one of its review
contractors will conduct a medical review and communicate a decision
that provisionally affirms or non-affirms the request.
We will issue specific prior authorization guidance in
subregulatory communications, including final timelines, which are
customized for the DMEPOS item subject to prior authorization, for
communicating a provisionally affirmed or non-affirmed decision to the
requester. In the December 30, 2015 final rule, we stated that this
approach to final timelines provides flexibility to develop a process
that involves fewer days, as may be appropriate, and allows us to
safeguard beneficiary access to care. If at any time we become aware
that the prior authorization process is creating barriers to care, we
can suspend the program.
III. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
Dated: December 1, 2016.
Andrew M. Slavitt,
Acting Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2016-30273 Filed 12-19-16; 4:15 pm]
BILLING CODE 4120-01-P